AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.03
-0.08 (-1.57%)
At close: Feb 27, 2026, 4:00 PM EST
5.07
+0.04 (0.80%)
After-hours: Feb 27, 2026, 4:17 PM EST
AVITA Medical Revenue
In the year 2025, AVITA Medical had annual revenue of $71.61M with 11.45% growth. AVITA Medical had revenue of $17.62M in the quarter ending December 31, 2025, a decrease of -4.30%.
Revenue (ttm)
$71.61M
Revenue Growth
+11.45%
P/S Ratio
2.15
Revenue / Employee
$316,858
Employees
226
Market Cap
154.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.61M | 7.36M | 11.45% |
| Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
| Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
| Dec 31, 2022 | 34.42M | 1.40M | 4.23% |
| Dec 31, 2021 | 33.03M | 15.11M | 84.32% |
| Dec 31, 2020 | 17.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| Treace Medical Concepts | 212.69M |
| InfuSystem Holdings | 143.44M |
| Electromed | 68.86M |
| LENSAR | 59.14M |
| Apyx Medical | 47.90M |
| SANUWAVE Health | 41.28M |
| Rapid Micro Biosystems | 30.52M |
RCEL News
- 4 days ago - AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 8 days ago - AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript - Seeking Alpha
- 15 days ago - AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Avita Medical: Set Up For A Turnaround - Seeking Alpha
- 6 weeks ago - AVITA Medical, Inc. (RCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook - GlobeNewsWire
- 7 weeks ago - AVITA Medical Announces Changes to its Board of Directors - GlobeNewsWire